Page last updated: 2024-10-31

methylphenidate and Dermatitis, Contact

methylphenidate has been researched along with Dermatitis, Contact in 2 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.

Research Excerpts

ExcerptRelevanceReference
" The methylphenidate transdermal system (MTS) is the first stimulant patch dosage formulation to be approved by the US Food and Drug Administration for the treatment of the symptoms of ADHD in children aged 6 to 12 years."2.44Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. ( Fowler, JF; Paller, AS; Warshaw, EM; Zirwas, MJ, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patrick, KS1
Straughn, AB1
Perkins, JS1
González, MA1
Warshaw, EM1
Paller, AS1
Fowler, JF1
Zirwas, MJ1

Reviews

2 reviews available for methylphenidate and Dermatitis, Contact

ArticleYear
Evolution of stimulants to treat ADHD: transdermal methylphenidate.
    Human psychopharmacology, 2009, Volume: 24, Issue:1

    Topics: Administration, Cutaneous; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervo

2009
Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Clinical therapeutics, 2008, Volume: 30, Issue:2

    Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2008